Who Paid My Doc
Inpen Smart Insulin Delivery System
Device Continuous Glucose Monitoring
PDI 10862088000344
General payments
$2,216,413
Research payments
$15,429
Through program year 2025, $2,216,413 in general payments and $15,429 in research payments were reported against Inpen Smart Insulin Delivery System (Continuous Glucose Monitoring).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $137,191 | 406 |
| 2025 | Research | $15,429 | 17 |
| 2024 | General | $1,694,587 | 471 |
| 2023 | General | $57,662 | 1,857 |
| 2022 | General | $326,973 | 6,718 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 33 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
9,452 general · 17 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.